MoFi is no more guilty of an ethical breach than any other advertiser. They all lie. The pharmaceutical industry is addicted to this game.
Washington Post article on MoFi vs. Fremer vs. Esposito
Here's a link to a Washington Post article on the recent dustup with MoFi. The comments section (including posts by Michael Fremer) are interesting.
Disclaimer: This is a "public service announcement, a point Im adding since some forum members complained the last article I referenced here was "paywall protected", I'll note that, for those who are non-subscribers, free access to limited numbers of articles is available by registering (trade-off: The Post will deluge you with subscription offers)